1. Home
  2. KLIC vs LQDA Comparison

KLIC vs LQDA Comparison

Compare KLIC & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kulicke and Soffa Industries Inc.

KLIC

Kulicke and Soffa Industries Inc.

HOLD

Current Price

$89.84

Market Cap

5.2B

Sector

Technology

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$89.34

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLIC
LQDA
Founded
1951
2004
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
5.5B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
KLIC
LQDA
Price
$89.84
$89.34
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$54.67
$41.00
AVG Volume (30 Days)
953.9K
1.3M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
0.98%
N/A
EPS Growth
100.32
51.81
EPS
2.06
0.52
Revenue
$654,081,000.00
$158,320,000.00
Revenue This Year
$45.81
$278.87
Revenue Next Year
$11.35
$57.13
P/E Ratio
$95.76
$171.38
Revenue Growth
N/A
1031.18
52 Week Low
$34.56
$19.02
52 Week High
$135.80
$91.36

Technical Indicators

Market Signals
Indicator
KLIC
LQDA
Relative Strength Index (RSI) 35.87 64.27
Support Level $81.62 $31.99
Resistance Level $89.59 $91.10
Average True Range (ATR) 6.25 4.89
MACD -0.90 0.01
Stochastic Oscillator 8.78 89.86

Price Performance

Historical Comparison
KLIC
LQDA

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc. is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments, which include Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: